$9.42
0.121.29%
At close: Sep 11, 5:00 PM EST
$9.50
0.07990.85%
After Hours: 7:51 PM EST
Novavax Inc
NVAXNASDAQ
Novavax Earnings & Forecasts
Novavax (NVAX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Novavax Guidance
Novavax (NVAX) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided revenue in the range of $235M - $275M for the period.
Compared to prior guidance, Novavax raised its revenue forecast from a prior range of $230M - $270M.
Novavax has issued 18 guidance updates between November 8, 2022 and August 6, 2026. During this period, the company raised its outlook 5 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.23 | $-0.56 | $-0.96 |
| Actual | $-0.32 | $-0.06 | $0.11 | $-0.48 |
| Surprise | +13.5% | +73.9% | +119.6% | +50.0% |
| Revenue | ||||
| Estimate | $51.7M | $76.9M | $85.5M | $42.8M |
| Actual | $56.7M | $139.5M | $147.1M | $70.4M |
| Surprise | +9.76% | +81.5% | +72.0% | +64.7% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.18 | $-0.07 | $-0.27 | $0.13 |
| Revenue | ||||
| Consensus | $74.9M | $98.1M | — | — |
